J&J, Takeda sales and marketing update

Takeda launched Reminyl galantamine in Japan to treat Alzheimer's disease (AD). Takeda has co-promotion rights to the drug in Japan from Johnson & Johnson's Janssen Pharmaceutical K.K., which will su...